.png)
through targeted radiopharmaceuticals
and
precision molecular imaging
Advancing next-generation radiotheranostic innovation from our U.S. headquarters.
Engineer targeted radiopharmaceutical solutions that deliver therapeutic radiation with unmatched precision—redefining how cancer is treated by improving efficacy, safety, and clinical impact.
To transform precision oncology by advancing next-generation radiotheranostic platforms that set new global standards for accuracy, scalability, and patient-centered cancer care.
Ayutara is a radiopharmaceutical company focused on developing next-generation targeted radioligand therapies and diagnostics for cancers with significant unmet need. We are building a pipeline of precision medicines that combine well-validated biological targets with innovative chemistry and scalable manufacturing approaches.
Our mission is to accelerate the development of safer, more effective therapies by advancing rigorous science, strong clinical rationale, and strategic collaborations with leading academic and research institutions. Through an integrated approach spanning discovery, radiochemistry, translational research, and IND-enabling development, Ayutara aims to deliver meaningful outcomes for patients and create long-term value for partners and stakeholders.
Next-generation radiopharmaceuticals for precision cancer therapy.
We are developing PSMA- and FAP-targeted radioligand therapies powered by Actinium-225 and Copper-64 for diagnosis and treatment of solid tumors.
Backed by cutting-edge research in nanocarriers, advanced chelators, and AI-driven drug design, Ayutara is building a pipeline of first-in-class theragnostic.
Discover Our TechnologyCutting-edge tools integrated within Ayutara to support safe, precise, and consistent delivery of radiopharmaceutical therapies.
Real-time dose assessment for kidney and bone marrow protection. Supports toxicity reduction through personalized dose optimization.
High-precision imaging to guide radiation delivery toward tumor tissue with improved accuracy and clinical confidence.
Automated handling systems designed to enhance radiation safety, consistency, and compliance during dose preparation.
Meet the scientists, clinicians, and innovators driving Ayutara’s mission to redefine precision cancer care.
Physician-scientists advising trial design, endpoints, biomarker strategy and theranostic workflows—bringing precision and practicality to every study.